Skip to main content
An official website of the United States government
Email

Cancer Therapy Evaluation Program (CTEP)

 Green background with circles radiating and fading from the right. White text on the left that states, “assesses new anticancer agents, radiation treatments, and surgical methods.”

The Cancer Therapy Evaluation Program (CTEP) manages a broad range of clinical trials that are closely integrated with preclinical discovery and development and biostatistical expertise fostered by other DCTD programs. 

Once a treatment approach has demonstrated promising efficacy and adequate safety in preclinical testing, CTEP-supported clinical trials networks and resources can move the therapy from first-in-human safety trials through definitive, randomized, controlled trials. 

CTEP also provides centralized infrastructure and support for other NCI-supported clinical trials networks, improving efficiency and reducing costs. 

Active and Upcoming Clinical Trials

View PDFs showing the latest portfolio of CTEP-supported cancer clinical trials open to enrollment in the NCTN and open or upcoming in the ETCTN (updated monthly).

Email